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Introduction: Tinnitus can become a strong stressor for some individuals, leading
to imbalance of the autonomous nervous system with reduction of parasympathetic
activity. It can manifest itself as sleep disturbances, anxiety and even depression. This
condition can be reversed by bioelectrical vagal nerve stimulation (VNS). Conventional
invasive VNS is an approved treatment for epilepsy and depression. Transcutaneous
VNS (taVNS) stimulating the auricular branch of the vagus nerve has been shown to
activate the vagal pathways similarly as an implanted VNS. Therefore, taVNS might also
be a therapeutic alternative in health conditions such as tinnitus-related mental stress
(TRMS). This retrospective study in 171 TRMS patients reports the clinical features,
psychophysiological characteristics, and results of the heart rate variability (HRV) tests
before and after test-taVNS. This study also reports the therapy outcomes of 113 TRMS
patients treated with taVNS, in combination with standard tinnitus therapy.
Methods: Diagnostic tinnitus and hearing profiles were defined. To detect possible
cardiac adverse effects, test-taVNS with heart rate monitoring as well as pre- and
post-stimulation HRV tests were performed. Daily taVNS home therapy was prescribed
thereafter. To assess therapeutic usefulness of taVNS, 1-year follow-up outcome
was studied. Results of HRV tests were retrospectively analyzed and correlated to
diagnostic data.
Results: The large majority of patients with TRMS suffer from associated symptoms
such as sleep disturbances and anxiety. Baseline HRV data showed that more than
three quarters of the 171 patients had increased sympathetic activity before test-
taVNS. Test-taVNS shifted mean values of different HRV parameters toward increased
parasympathetic activity in about 80% of patients. Test-taVNS did not cause any
cardiac or other side effects. No significant adverse effects were reported in follow-
up questionnaires.
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Conclusion: TRMS is an example of a stress condition in which patients may benefit
from taVNS. As revealed by HRV, test-taVNS improved parasympathetic function, most
efficiently in patients with a low starting HRV level. Our tinnitus treatment program,
including taVNS, effectively alleviated tinnitus stress and handicap. For wider clinical
use, there is a great need for more knowledge about the optimal methodology and
parameters of taVNS.
Keywords: stress, tinnitus, patients, parasympathetic, vagus, neuromodulation
INTRODUCTION
All our unconscious bodily functions are controlled by the
autonomic nervous system (ANS), particularly by the CAN
(Benarroch, 1993). The most common cause for the dysfunction
of CAN is stress, the major cause of deteriorating health
conditions and illnesses. CAN initially reacts to stressor effects
with sympathetic fight/flight response that is restored back to
normal by the parasympathetic nervous systems´ relax/digest
response (Selye, 1950). Many illnesses result from the inability
of the parasympathetic activity to restore the ANS balance
(for review see McEwen, 2000; McEwen and Akil, 2020).
These two circuits, sympathetic and parasympathetic systems,
are constantly interacting. This interaction is reflected by
HRV that, hence, is a read out of ANS balance. HRV may
consequently serve as a measure of stress (Akselrod et al.,
1981; Thayer et al., 2012). As the vagal system with the
vagus nerve in front is responsible for parasympathetic activity,
neuromodulation via VNS can serve as targeted treatment in
stressful conditions. VNS has been conventionally performed for
more than two decades to treat severe epilepsy and depression
by applying an electrode surgically implanted to the cervical
trunk of the vagus nerve. More recently, it has been shown
by electrophysiological and neuroimaging studies that taVNS
of the ABVN activates central vagal pathways similarly as
VNS with an implanted electrode (Kraus et al., 2007; Dietrich
et al., 2008; Frangos et al., 2015; Yakunina et al., 2017;
Badran et al., 2018a).
ANS imbalance is most often a result of the individual’s
exposure to concurrent stressors. Therefore, the stress-triggered
clinical picture is often very heterogeneous. On the contrary,
tinnitus (ringing in the ears) as a stressor usually results
in a relatively regular SR in otherwise healthy individuals.
Therefore, individuals with TRMS seem to be an optimal
target group for investigations of the effects of taVNS on
stress in patients.
Tinnitus is considered to be generated in the auditory
periphery (cochlea-cochlear nerve), detected in the subcortical
Abbreviations: ABVN, auricular branch of the vagus nerve; AF, atrial fibrillation;
ANS, autonomous nervous system; CAN, central autonomic network; CNS,
central nervous system; ECG, electrocardiogram; HR, heart rate; HRV, heart rate
variability; MIT, music-induced tinnitus; NIHD, noise-induced hearing disorder;
NIT, noise-induced tinnitus; NTS, nucleus tractus solitarius; SR, stress reaction;
taVNS, transcutaneous VNS; TCPT, tinnitus care pathway technology; THI,
tinnitus handicap inventory; TRMS, tinnitus-related mental stress; TRT, tinnitus
retraining therapy; VAS, visual analog scale; VNS, vagal nerve stimulation; VSEP,
vagal somatosensory evoked potential.
centers according to the lines of pattern recognition principles,
and perceived and evaluated in the auditory cortex with
significant participation of the limbic system and prefrontal
and other cortical areas (Jastreboff, 1990). Tinnitus sound itself
usually constitutes only minor symptoms. However, tinnitus
connected with fear (that it is maintained or even growing worse)
and threat (that it is a sign of a serious illness) leads to automatic
negative thoughts, developing a SR (arousal) that may potentiate
sleep problems, anxiety and depression. The end result all of this
is a vicious cycle, SR worsening tinnitus and increased tinnitus
worsening stress.
This was taken into consideration in the neurophysiological
tinnitus model by Jastreboff (1990) and it formed the basis
for the development of the TRT program (Jastreboff and
Hazell, 1993). The target of TRT therapy is the stress-
arousal caused by tinnitus and it leads to distress that
prevents habituation. The goal of TRT is to remove the
negative perception of tinnitus from patient’s consciousness,
thereby facilitating habituation. Furthermore, the rationale of
TRT is to attenuate the conditioned stress-response (arousal)
with associated sympathovagal imbalance by stimulating the
parasympathetic system (Jastreboff and Hazell, 1993). TRT is a
program consisting of diagnostics, instructive counseling and
sound therapy, each acting in concert with the aim to stimulate
the parasympathetic system.
Plans for this study were started after Engineer et al. (2011)
reported that maladaptive neuronal plasticity of the central
auditory system, thought to be behind tinnitus in an animal
tinnitus model, can be reversed through (invasive) VNS. It was
clear that conventional (invasive) VNS would not be the optimal
treatment for patients with tinnitus. Therefore, we first had to
develop a method and device for noninvasive VNS (taVNS).
When the device development was completed, we had to start to
test-use it particularly for cardiac safety.
This retrospective study reports the clinical, audiological and
psychophysical diagnostic results in a historical group of 171
patients managed for TMRS. The study also reports the results
of the 1-year follow-up outcome study with patients treated with
taVNS. Because stress levels of patients needed to be measured
and because of the novelty of taVNS and the potential cardiac
complications reported by VNS, the HRV test and test-taVNS
with HR monitoring were considered obligatory. We performed
HRV test both before and after test-taVNS. Our data show
that taVNS is safe and improves parasympathetic activity and,
in conjunction with TRT, attenuates tinnitus severity based on
results of symptom questionnaires.
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PATIENTS AND METHODS
The present series consists of 171 consecutive patients (67 female,
104 male, mean age 49 years, range 17–84) who visited the
Tinnitus Clinic of Helsinki Ear Institute between November 2014
and December 2017 due to annoying tinnitus. We have developed
our own modification of TRT that is named TCPT. Its main
constituents include diagnostic profiling of tinnitus and hearing,
counseling, sound therapy, and a sleep module. In order to
strengthen parasympathetic activation, taVNS was added to the
program in 2014. In addition to other diagnostics, HRV tests and
a 15–60 min test-taVNS were performed and, as adjunctive to
other TCPT therapy, a taVNS device was prescribed as home-
therapy if tinnitus had been defined as moderate or severe (THI,
questionnaire score higher than 34/100). Some patients with
lower THI scores were also instructed for taVNS treatment if
they showed special interest in the device or complained of being
particularly stressed. At the initial office visit, extensive otological
and audiological examinations with profiling of tinnitus and
hearing were done using different structured diagnostic forms
and questionnaires. For clinical evaluation of the subjective
severity of tinnitus annoyance and associated symptoms such
as sleep disturbance and anxiety levels were quantified based
on VAS questions.
Each patient’s stress level was evaluated by HRV testing. The
patient was then (for safety reason) test-stimulated with the
Salustim taVNS device (Helsinki Ear Institute) continuously for
15–60 min after which a new HRV test was performed. We have
earlier shown by magnetoencephalography that the amplitudes
of auditory N1m responses in the auditory cortex are reduced by
using this taVNS method (Lehtimäki et al., 2013). As there were
no adverse effects related to the test-taVNS, all tested patients
were then instructed to use the taVNS device at home 60–90 min
per day. The long-term therapeutic outcomes of our first 113
patients were studied with structured questionnaires about 1 year
after the first visit. Such follow-up data was possible to obtain
during office visits scheduled according to the TCPT program or
by telephone interviews in 78 patients (69%) (54 males and 59
females; age range from 18 to 84 years).
HRV Test and Heart Rate Monitoring
During Test-taVNS
The main aim of HR monitoring was to detect possible cardiac
side-effects during the first 15–60 min of taVNS stimulation.
Other reasons were to measure the mental stress level of
patients and to collect HRV data for later analyses to study
whether HRV could be used for selection of presumably
taVNS-responding patients. In this study, we report the results
of HRV analyses and specifically correlate HRV results to
clinical data in a total of 171 patients. We have previously
described in detail our HRV testing procedure (Ylikoski et al.,
2017). Briefly, for analyzing the dynamics of HRV signals (R-
R intervals), the eMotion HRV measurement system (Mega
Electronics Ltd., Kuopio, Finland) was used. Stress test with a
HRV scan was performed with the patient breathing with a
parasympathetic stimulating respiratory rate during which the
R-R interval variability was registered by wrist electrodes with
a one-lead ECG. In the eMotion HRV measurement, artifacts
and interruptions were eliminated with high-end technology
(and disposable surface electrodes) (Malik, 1996; Tarvainen
et al., 2009). Only tests with 100% measurement quality in
ECG monitoring were used for evaluation. The following HRV
parameters were measured during the 1-min deep-breathing test
(one-min DBT): mean HR, amplitude and ratio of HR oscillation
(E-I difference, E/I ratio) (E-I = difference between the highest
and the lowest HR within a breathing cycle), RMSSD (root
mean square of the successive differences), SDNN (standard
deviation of the R-R intervals), and Power LF (LF = low
frequency; 0.04–0.15 Hz). One-min DBT was followed by 5-
min short-term HRV (s-HRV) where the HRV parameters
HR, SD1 (width of the Poincare plot, reflecting short-term
variability), SD2 (length of the Poincare plot, reflecting short-
term variability), SDNN, Stress Index, Power HF (HF = high
frequency; 0.15–0.4 Hz), Power LF, Power VLF (very low
frequency), and Total Power were determined as well. Parameters
were compared through correlation analysis and agreement
analysis by Bland-Altman plots. The results of HRV tests
were evaluated on the basis of eMotion tests performed in
normal individuals (Camm et al., 1996; Tarvainen et al., 2009;
Weinschenk et al., 2016).
Vagal Somatosensory Evoked Potential
Test
In order to biomonitor the electrical stimulation of ABVN, we
measured the VSEP response (Fallgatter et al., 2003). We used
EGI GTEN 100 EEG system with 8 kHz collection rate (256
electrodes) (Palva and Palva, 2018) and with different stimulation
parameters. We used uni- or bipolar pulses, pulse width 100–560
microseconds, frequencies 1, 2, 4, 8, 15, 20, 25, 30 Hz, amplitude
at or just below the pain threshold, and delivered 200–500 epochs
at each setting.
taVNS
We used the taVNS instrument consisting of one ear clip
electrode connected to a wired TENS-neurostimulating device
(Salustim, Helsinki Ear Institute). The clip-electrode was placed
on the tragus of the left ear. The clinical efficacy of taVNS
requires activation of the thick myelinated afferent fibers of the
vagus nerve. Fibers of a sensory peripheral nerve, such as the
ABVN, mediate touch sensation. Consequently, the stimulus
intensity of taVNS will be adjusted to a level above the individual’s
detection threshold and clearly below the individual’s pain
threshold. The taVNS device offers a stimulus intensity between
0.1 and 30 mA with a stimulation frequency of 25 Hz and
pulse duration of 250 µs. After the individual adjustments the
level of stimulation in patients ranged from 0.3 to 3.0 mA.
The 15–60 min continuous test stimulation was performed
under medical supervision in the office, with continuous HR
monitoring. After the initial test stimulation, patients were
instructed to use the taVNS device at home for 60–90 min
daily, 5 days a week.
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Statistical Analyses
Statistical analyses were performed using GraphPad Prism 8
(GraphPad Software, La Jolla, CA, United States). Normality
of data was tested with D’Agostino & Pearson test. The non-
parametric Wilcoxon’s matched pairs signed rank test was used
to estimate the p-values between pre/post -taVNS data, as all data
did not follow a normal distribution. Comparison between age
groups was also done using the non-parametric Kolmogorov–
Smirnov test. Comparison between super-responders vs. non
-responders was done using unpaired two-tailed Student’s t-test
as the data followed a normal distribution. Data is presented
as mean ± standard deviation (SD). Statistical significance was
set up at P < 0.05. Bonferroni adjustment were performed for
multiple comparisons by dividing the initial significance level of
0.05 by the number of tests to obtain a modified significance
level. Treatment effect sizes were calculated by Cohen’s d as the
difference in means, divided by the pooled standard deviation of
the two means (Cohen’s, 1988). The magnitude of Cohen’s d can
be expressed as small (0.2), moderate (0.5), and large (0.8).
RESULTS
Baseline Values
All the patients had clinically relevant tinnitus; chronic in two
thirds, subchronic in about 20% and acute (tinnitus duration
less than 3 months) in about 15%. In acute cases, most patients
had visited our tinnitus clinic one to 6 weeks after the start
or worsening of tinnitus. The most common cause of tinnitus
was acoustic overstimulation (“NIT”, 47%), usually of a result
of exposure to loud music in a festival or restaurant. About one
third of NIT cases was defined as music-induced tinnitus (MIT).
The MIT patients were usually professional or hobby musicians.
Other causes were self-reported stress (6%), otitis media (4%) and
other causes such as flight travel (2%). The cause of tinnitus was
unknown in 40% of cases (Figure 1A).
Otological examinations were normal and there were no
audiometrically detectable acute hearing impairment, except in
five patients that had been exposed to shooting noise. They had
a mild (10–25 dB) dip-type hearing loss either at 4 or 6 kHz.
Two thirds of patients showed normal or age-related hearing loss
in pure tone audiometry. Tinnitus was high-pitched (8 kHz or
higher) in two thirds (66%) and >4 kHz in about 85% of cases.
The most common tinnitus frequency was detected between 7
and 9 kHz (27%), followed by 11–14 kHz (19%), 9–11 kHz (14%)
and 5–7 kHz (13%) (Figure 1B).
The mean THI was 55, and it was between 34 and 100 in
81% of patients indicating moderate or severe tinnitus (Figure 2).
Tinnitus was frequently associated with sleep disturbances (92%)
and anxiety (96%) (Figure 2). Both sleep disturbances and
anxiety were severe or very severe (above 50/100 in VAS in more
than half of the patients (57% and 54%, respectively). It may
be noteworthy that the patients were typically stressed because,
prior to visiting us, they had visited general practitioners or ENT
specialists and had received negative counseling (“nothing can
be done”, “you just have to learn to live with it”). One third of
patients had a history or ongoing therapy of depression, ranging
from mild (12%) to moderate (18%) to severe (3%).
FIGURE 1 | (A) The most common cause of tinnitus was acoustic overstimulation (noise-induced tinnitus, NIT; 47%), followed by self-reported stress (6%), otitis
media (4%) and other causes (2%). The cause was unknown in 40%. (B) The most common tinnitus frequency was between 7 and 9 kHz (27%), (marked as 8),
followed by 11–14 kHz (19%), (marked as 12), 9–11 kHz (14%), (marked as 10), 5–7 kHz (13%), (marked as 6). In 9 patients (5%) tinnitus frequency was >14.0 kHz,
in 17 patients (10 %) between 3 and 5 kHz (marked as 4), in 11 patients (7 %) between 1 and 3 kHz (marked as 2) and in seven patients (4%) < 1.0 kHz.
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FIGURE 2 | THI was between 34 and 100 in 81% of patients. The mean THI
value was 55 and the mean VAS-scaled (0–100) values of both loudness and
annoyance were 55. Tinnitus was associated with sleep disturbances in 92%
and with anxiety in 96%, both being severe or very severe (>50/100 in VAS
scale) in 57% and 54% of patients, respectively.
HRV Tests and Results of Test-taVNS
The main aim of the initial test-taVNS was to ascertain the
cardiac safety of the method. We found no cardiac adverse
effects in our 171 patients. This applies actually to more than
250 taVNS patients treated so far by us: none of them reported
cardiac or other serious side-effects during the first test-taVNS
or during home treatment. Several of our patients have used
the taVNS device regularly, practically daily for 2–3 years,
some up to 5 years.
Baseline data from 1-min DBT-HRV and 5-min short-
term HRV (s-HRV) showed that more than three quarters of
TRMS patients had increased sympathetic activity before test-
taVNS. This was deduced from the stress index (data not
shown) and the HRV age, which was in this patient population
approximately 16 years higher than the mean chronological age.
Table 1 shows the mean values of different HRV parameters,
considered to describe the vasovagal tone and the changes of
HRV parameters immediately after the 15–60 min test-taVNS.
The taVNS significantly increased all HRV parameters: the mean
R-R interval in 81%, Flexibility = E-I (difference between the
highest and the lowest heart rate within a breathing cycle) in
63%, Dynamics = RMSSD, (root of the mean square of successive
differences) in 69%, Tone = mean HR in DBT in 68% of patients,
and decreased the HRV age by 9 years (Table 1).
From our previous experience (Ylikoski et al., 2017) and from
the results of the current study, we deduced that R-R interval,
HRV age and RMSSD are the most useful markers for stimulation
changes in HRV (Table 1). RMSSD is mainly related to beat-to-
beat variations reflecting parasympathetic output (Faber et al.,
1996). In practice, the change in vasovagal tone is best illustrated
by the HRV age that was determined by algorithms based on
values of HRV parameter values, as described by Weinschenk
et al. (2016).
If in cases where R-R interval was decreased (in 19%)
after test-taVNS, the results of HRV age were taken into
consideration, either the HRV age or R-R interval showed
increased parasympathetic activity in more than 95% of cases.
To compare the changes in R-R interval, RMSSD and HRV
age with the age of patients, we selected the youngest patients
(age < 41 years) for one group (n = 41) and the oldest
patients (age > 63 years) for another group (n = 21) (Table 2,
Figure 3). Test-taVNS increased all the three HRV parameters
much more often in patients of the older group: R-R interval
in 86% in >63 group, 73% in < 41 group, RMSSD in 81%
in >63 group, 66% in < 41 group and HRV age in 81%
in >63 group, 58% in < 41 group (Table 2). The taVNS-
induced numerical increases of the three HRV parameters were
also greater in the older patients. However, only the RMSSD
changes reached statistical significance (Table 2, Figure 3).
This indicates that taVNS is more efficient in older patients, a
result that could be explained by lower starting levels of HRV
in this group due to age-related decline in parasympathetic
activity. The magnitude of taVNS-induced changes has been
shown to be higher in individuals with lower starting HRV level
(Bretherton et al., 2019).
TABLE 1 | Mean HRV test data of 171 patients with TRMS.
R-R-interval HRV-age Flexibility % Dynamic % (RMSSD) Tone %
pre/post taVNS pre/post taVNS/chronol pre/post taVNS pre/post taVNS pre/post taVNS
Mean 815/868 65/56/49 32/44 32/49 38/49
SD 141/140 22/23/16 28/30 30/34 30/30
p-Value <0,0001 <0,0001 <0,0001 <0,0001 <0,0001
Cohen’s d 0,377 0,400 0,414 0,530 0,367
taVNS induced change +52 (6.4%) −9 (13.7%) +11 (34.5%) +18 (53.2%) +12 (30.5%)
Increased 139 (81.3%) 12 (7.0%) 107 (62.6%) 118 (69.0%) 116 (67.8%)
Decreased 32 (18.7%) 135 (79.0%) 36 (21.1%) 16 (9.4%) 22 (12.9%)
Unhanged – 24 (14.0%) 28 (16.4%) 37 (21.6%) 33 (19.3)
The taVNS significantly increased all HRV parameters: the mean R-R interval in 81%, Flexibility in 63%, Dynamics (RMSSD) in 69%, Tone in 68% of patients, and decreased
the HRV age by 9 years. The mean pre-taVNS HRV age was 16 years higher than the chronological age. The taVNS induced change represents the mean difference
between pre- and post-taVNS values of all patients. The mean percentage change is also shown. Increases of RR-interval, flexibility, RMSSD and tone and decrease of
HRV-age indicate increased parasympathetic or decreased sympathetic tone. Pre = baseline data; post = post-taVNS stimulation data. Wilcoxon’s matched pairs signed
rank test was used to calculate p-values. The Bonferroni adjustment method for multiple testing produced a rejection p-value of 0.01. All p-values remained statistically
significant. Effect sizes (Cohen’s d) ranged from small to medium, the largest was observed in Dynamic % (RMSSD).
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TABLE 2 | Correlations between HRV parameters and scores of sleep and anxiety
between age groups.
R-R-interval HRV-age RMSSD sleep/anxiety
pre/post
taVNS
pre/post
taVNS
pre/post
taVNS
All patients
(n = 171)
+52 (6.4%) −9 (13.7%) +18 (53.2%) 55
<41 year,
n = 41
+53,6 (6,9%) −7,76 (−15,5%) +15,2 (42,6%) 61
>63 year,
n = 21
+85,0 (10,5%) −11,7 (−14,7%) +30,1 (93,3%) 52
p-Values 0,515 0,0718 0,0392 0,456
Cohen’s d 0,395 0,315 0,574 0,276
Correlations between HRV parameters (R-R interval, HRV age and RMSSD), and
scores of questionnaires for sleep and anxiety between Group A (age < 41 years)
and Group B (age > 63 years). Test-taVNS increased all three HRV parameters
much more often in patients of the older group: R-R interval in 86% in >63,
73% in < 41 groups, RMSSD 81% in >63, 66% in < 41 groups and HRV age
81% in >63, 58% in < 41 group. Shown is the mean taVNS induced change
(mean difference between pre- and post-taVNS values) of all patients as well as of
the two age groups. The taVNS-induced numerical increases of these three HRV
parameters were also greater in the older group. Only the RMSSD changes reached
statistical significance using the non-parametric Kolmogorov–Smirnov test (when
comparing mean changes between the two groups) That significance was removed
by the Bonferroni correction as the adjustment for multiple testing produced a
rejection p-value of 0.0125. Effect sizes (Cohen’s d) ranged from small to medium,
the largest was observed in Dynamic % (RMSSD). A positive effect means that the
change of the>63 years group was larger than the change of the<43 years group.
FIGURE 3 | Correlations between HRV parameters between Group A (below
41 years) and Group B (above 63 years) shown in Table 2. The
taVNS-induced numerical increases of these three HRV parameters were
greater in the older group. However, only the RMSSD changes reached
statistical significance.
To compare taVNS responses to questionnaire-based
clinical data, we selected two patient groups, based on the
magnitude of taVNS responses. Group A (21 patients) consisted
of super-responders showing a post-taVNS RMSSD increase
of 400–2000%. Group B (43 patients) consisted of non-
responders showing unchanged or decreased post-taVNS
RMSSD. Comparison of the values of THI, sleep disturbance
and anxiety showed that group A comprized of more patients
with mean THI scores > 60/100 and with sleep disturbance
and anxiety scores > 60/100. However, the differences were not
statistically significant (Table 3, Figure 4). Super-responders had
also higher average tinnitus pitch (8.4 kHz) than non-responders
(6.6 kHz) (Table 3, Figure 4).
Results of VSEP Testing
There was a strong stimulation artifact (0 ms) after which
oscillations were registered at about 3 ms. These have been earlier
described to be of brainstem origin (VSEP) (Fallgatter et al.,
2003). This response, however, was interpreted and presumed to
be of local origin, arising from muscles in the ear region, not in
the brainstem, in accordance to Leutzow et al. (2013). Therefore,
we have not used VSEP as a biomarker for taVNS.
Results of the 1-Year Follow-Up
Outcome Questionnaires
One-year follow-up therapeutic outcome data was possible to
receive from 78 out of 113 patients (69%). Both the loudness
and annoyance of tinnitus had decreased in about two thirds
and, importantly, stress had decreased in more than 80% of
patients (Figure 5A). About 76% of patients reported that they
had benefited from the TCPT (including taVNS) treatment.
When asked whether they would recommend similar treatment
for a friend or near relative with similar health problems, 90%
answered yes or probably yes (Figure 5B). When asked what
constituent of the TCPT therapy regimen was most efficient
in 1 to 5 scale, counseling showed an efficacy of 3.4, followed
by taVNS (3.1) and sound therapy (2.8) (Figure 5C). Thus, it
seems that taVNS is a useful addition to tinnitus treatments. We
stress, however, that the most important constituent of tinnitus
therapy is directive counseling. That has been our opinion for
decades and it was also supported by the results of this follow-
up study.
DISCUSSION
The main aim of this study is to share our experience of the usage
of taVNS in the treatment of distressing tinnitus. Therefore, we
discuss only matters that we feel important in clinical practice.
Our study shows that taVNS is safe. Baseline HRV data of
171 patients showed that more than three quarters of TRMS
patients had increased sympathetic prevalence (preponderance)
before the first test-taVNS. The mean values of different HRV
parameters changed toward increased parasympathetic activity
by test-taVNS in about 80% of patients. These changes were more
pronounced in patients showing greater tinnitus handicap, more
severe associated symptoms, higher stress levels and higher age
before the test stimulation. No significant adverse effects were
reported in follow-up questionnaires. Our conclusion is that our
tinnitus treatment program, including taVNS, alleviates stress
and handicap caused by tinnitus.
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TABLE 3 | Comparison between taVNS responses and questionnaire-based clinical data in super-responders and non-responders.
THI Sleep Anxiety Loudness Annoyance Frequency
A. Super responders (RMSDD increase 400–2000%) 61,05 (n = 21) 70,00 (n = 20) 68,95 (n = 19) 67.35 (n = 19) 74.12 (n = 19) 8398 Hz (n = 20)
B. Non-responders (decrease or no change) 56,67 (n = 43) 61,22 (n = 37) 58,11 (n = 37) 60,63 (n = 37) 70,47 (n = 37) 6562 Hz (n = 40)
p-Values 0,246 0,642 0,198 0,147 0,197 0,122
Cohen’s d 0,301 0,128 0,358 0,429 0,386 0,414
Comparison between taVNS responses and questionnaire-based clinical data and tinnitus frequency in two patient groups. Group A (n = 21): super-responders (taVNS-
induced RMSSD increase of 400–2000%). Group B (n = 43): non-responders (RMSSD decreased or unchanged). The mean values of THI, sleep disturbance, anxiety
and tinnitus frequency were all greater in group A, but the differences were not statistically significant (Student’s t-test). Bonferroni adjustment method for multiple testing
produced a rejection p-value of 0.0083. Effect sizes (Cohen’s d) ranged from small to medium. A positive effect indicates that the mean of the super-responder group
was larger than the mean of the non-responder group.
FIGURE 4 | Comparison between taVNS responses and questionnaire-based clinical data and tinnitus frequency in groups A (super-responders) and B
(non-responders), shown in Table 3. The mean values of THI, sleep disturbance, anxiety and tinnitus frequency were all greater in group A, but the differences were
not statistically significant. Error bars represent standard deviations. THI = tinnitus handicap inventory.
FIGURE 5 | (A) Results of 1-year-follow-up outcome of 113 patients of which 78 (69%) data was received. Tinnitus annoyance had decreased in 72% and
tinnitus-triggered stress in 82%. Symptoms had increased in 2%. (B) 76% of patients reported that they had benefited from TCPT treatment, including taVNS; 41%
would recommend and 52% possibly recommend TCPT plus taVNS t for a friend or relative if suffering from similar health problems. (C) Of the components of
treatment, counseling was reported most helpful (score 3.4 from the range 1–5), followed by taVNS (3.1) and sound therapy (2.8).
The main problem of patients with disturbing moderate or
severe tinnitus is usually TRMS (Andersson and Hesser, 2013)
and associated imbalance of the ANS, leading to sympathetic
prevalence and correspondingly reduced parasympathetic
activity (Thayer et al., 2012; Chalmers et al., 2014). Therefore,
the optimal TRMS treatment would be by trophotropic
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(parasympathetic activity enhancing) means. This could be
achieved by behavioral methods such as cervical vagal massage,
Valsalva maneuver or respiratory VNS (Gerritsen and Band,
2018) or by general relaxation generating methods such as yoga,
mindfulness, biofeedback and cognitive behavioral therapy. The
present study, in agreement with our previous results (Ylikoski
et al., 2017), suggests that the therapeutic trophotropic effect
can be accentuated by taVNS in TRMS and, thereby, tinnitus
handicap can be attenuated. This would be in accordance with
recent studies reporting that (implanted) VNS paired with tones
as well as taVNS constitute promising novel treatments for
tinnitus (Lehtimäki et al., 2013; Tyler et al., 2017; Yakunina et al.,
2018). On the other hand, another clinical study did not report
improvement of tinnitus with taVNS alone, although the therapy
was found to be safe (Kreuzer et al., 2014).
The vagus nerve provides a unique therapeutical entrance to
the CNS. Although VNS has become an established intervention
therapy for therapy resistant epilepsy and depression, the
exact mechanisms remain unsolved. Preclinical studies have
shown that VNS therapy results in intermittently increased
release of multiple neuromodulators, including norepinephrine,
acetylcholine, serotonin and brain-derived neurotrophic factor
(BDNF) (Hassert et al., 2004; Dorr and Debonnel, 2006). BDNF
is a key player in the CNS neuronal plasticity. Maladaptive
plasticity is thought to be involved in many medical entities,
particularly in illnesses such as phantom pain, dystonias and
tinnitus (Flor et al., 2001; Engineer et al., 2011; Kilgard, 2012). In
addition, enhancement of neuronal plasticity through VNS has
been shown to improve functional recovery in animal models
and patients with stroke-induced upper limb paresis (Dawson
et al., 2016; Engineer et al., 2019) and in animal models of spinal
cord injury (Ganzer et al., 2018). BDNF, norepinephrine and
serotonin have been suggested to play a key role in this enhanced
plasticity (Hulsey et al., 2017). BDNF is an activity-dependent
neurotrophic factor (Barde et al., 1982). Therefore, therapeutic
sessions have consisted of VNS combined with simultaneous
activities such as physical therapeutic movements in upper limb
paresis or pairing with tones in tinnitus (Engineer et al., 2011;
Dawson et al., 2016). In depression, the activity part is thought to
consist of psychotherapy.
We emphasize that taVNS should not be applied as a solo
but an adjunctive therapy. In our study the treatment of patients
with distressing tinnitus was always started with a 1.5 h office
visit during which patient‘s complaints were dealt with our
TRT modification, the TCPT program. This consists of careful
diagnostics with hearing and tinnitus profiling, counseling and
instructions for sound therapy. The taVNS has been the fourth
component of TCPT, initiated at the office visit and continued,
together with sound therapy (the activity component), as home
therapy. Our inquiries (Figure 5) indicate that counseling is the
most important therapy constituent for this kind of distressed
patients. During counseling, which takes about 1 h, we try to
demystify tinnitus by explaining what tinnitus is all about and
how one should behave in order to diminish its annoyance; not
to be afraid that it worsens or never disappears. It has been
shown that uncertainties and fears constitute a potent stressor
and can easily cause diseases (Peters et al., 2017). Specifically,
fear and anxiety can be significant co-factors, possibly modulated
by amygdala, in triggering TRMS (Andersson et al., 1999; Cima
et al., 2012). This type of counseling should be applied also to the
therapeutic regimen of anxious and depressive patients.
Mechanisms of TRMS
The prominent feature of our patients was the SR (arousal)
caused by tinnitus. SR is such a personal experience that it is
not possible to ascertain – or even speculate- why most of the
patients had developed a severe SR. Also, the reliability of our
main markers for SR, the questionnaires and HRV tests, are
not accurate and often even debatable. However, there are some
general clinical and test-based characteristics, which allow to
suggest speculative stress pathways at least in the patients in
which tinnitus was initially triggered by exposure to excessively
loud sounds. These patients had contracted NIHD that is now
known to be the most common consequence of noise trauma.
Its most common symptoms are tinnitus and hyperacusis, the
audiometrically measurable hearing impairment being a much
less common feature (Kähäri et al., 2001; Szibor et al., 2018).
Usually, the intensity of the exposing sound (mostly music) is
relatively low in NIHD and its action on the cochlea is thought
to be cellular stress/damage that does not lead to significant
hair cell loss. Low-level noise exposure is known to cause
synaptopathy, the damage of the synapses between inner hair
cells and auditory nerve fibers (Kujawa and Liberman, 2009). It
is generally accepted that tinnitus frequency and the predicted
location of the lesion along the tonotopic axis of the cochlear
are closely related. In the present study, tinnitus frequency
tended to be very high, higher than 6 kHz in more than 85%
of cases, indicating that the presumable cellular stress response
was localized to the extreme basal coil of the cochlea. Most
researchers agree that tinnitus can be linked to changes at one or
more relays along the peripheral and central auditory pathways
including auditory cortex (Jastreboff, 1990; Lockwood et al., 1998;
Giraud et al., 1999; Møller, 2003; Eggermont and Roberts, 2004;
Rauschecker et al., 2010). Although it is generally accepted that
the dysfunction of the auditory system is necessary for tinnitus to
occur, it is unclear whether this defect alone is sufficient to cause
chronic tinnitus or whether additional mechanisms outside the
auditory-sensory regions are involved. Clinically, there is a clear
relationship between tinnitus and the emotional state (Sullivan
et al., 1988; Dobie, 2003) and it has led to the suggestion that
the limbic system plays a role in modulating or perpetuating
tinnitus (Jastreboff, 1990; Rauschecker et al., 2010). Indeed, the
lifetime incidence of clinical depression in tinnitus patients is
estimated to be more than twice of the national average (∼35%
vs. 15%, respectively, Folmer et al., 1999). Treatment regimens
that include forms of cognitive-behavioral therapy have been
shown to be effective for many tinnitus patients (Jastreboff,
2007; Robinson et al., 2008). Although the exact nature of the
involvement of the limbic system in chronic tinnitus remains to
be shown, there is substantial – mainly neuroimaging – evidence
indicating that networks such as the corticostriatal circuit and
the amygdala-anterior cingulate cortex axis are involved (Leaver
et al., 2011; Chen et al., 2017; Xu et al., 2019). It has been
shown that the corticostriatal circuit, which includes the nucleus
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accumbens and ventromedial posterior frontal cortex, does
indeed differ in the brains of individuals with tinnitus (Leaver
et al., 2011). The corticostriatal circuit is part of the general
“appraisal network”, determining which sensations are important
and ultimately affecting how (or whether) those sensations
are experienced (Simmons et al., 2020). Our theory of the
pathogenetic mechanism of NIHD is schematically summarized
in Figure 6.
The Inflammatory Reflex or
Neuroinflammation in the Pathogenesis
of Stress and Tinnitus, and Possible
Attenuation by taVNS
Although the common pathways between stress exposure and
pathophysiological processes leading to tissue damage are still
debatable, several results indicate that stress can activate an
inflammatory response in the brain and in the periphery
(Calcia et al., 2016, for review). In this damaging process,
stress-induced pro-inflammatory factors including C-reactive
protein, IL-6, TNFα, IL-1β and NF-κB, have an important role
(Miller et al., 2008). In common, over-activated immune system,
increased sympathetic nervous system activity and reduced
glucocorticoid (GC) responsiveness may work tandemly in
the activation of inflammatory responses during stress. GCs,
catecholamines, cytokines and other mediators are thought to
be the main mediators of the stress-induced pro-inflammatory
effect. Correspondingly, when the auditory system in a
rodent model was exposed to acoustic overstimulation causing
hearing impairment and tinnitus, neuroinflammation in the
central auditory system was found to be importantly involved
(Wang et al., 2019).
After exposure to acoustic overstimulation from loud noise or
music, the resulting tinnitus is high-pitched (Szibor et al., 2018).
It can be very difficult to tolerate and habituate this tinnitus and,
therefore, it may lead to sleep disturbances, anxiety and finally to
SR. Tinnitus can be regarded as the consequence of multisensory
interactions between the auditory and limbic systems. This
is because extensive functional networks and tinnitus distress
strongly correlate with enhanced effective connectivity that is
directed from the amygdala to the auditory cortex (Rauschecker
et al., 2010; Chen et al., 2017). When the stimulation patterns and
dynamics of functional networks during VNS were examined by
fMRI, the vagus nerve was found to convey signals to the brain
through the polysynaptic neuronal pathways, by projecting to the
brainstem nuclei (NTS, locus coeruleus), subcortical areas and
lastly to the cortex (Henry, 2002; Ressler and Mayberg, 2007),
thus covering the entire CAN. fMRI and a spatially independent
component analysis were utilized in a recent experimental study
(Cao et al., 2017). That study demonstrated that VNS activated
15 out of 20 brain networks and that the activated regions
covered > 75% of the brain volume.
Very soon after the acoustic trauma, which means during
ongoing inflammatory response or neuroinflammation, patients
usually seek medical assistance because of uncertainty (and
fear) with questions regarding possible consequences and
management. If no appropriate treatment or even counseling are
available and only negative counseling is offered (“nothing can
be done”), a complete SR with self-perpetuating cycle develops:
distress worsens tinnitus and worsening tinnitus accentuates
SR. This is about the clinical picture characterizing most of
the patients included in the present study. Therefore, it is not
surprising that our TCPT therapeutic regimen, including taVNS
as the adjunctive treatment, significantly benefited the great
majority of patients. In this type of condition, taVNS may be
especially effective, perhaps due to a dual action: it may attenuate
the underlying neuroinflammation or inflammatory process in
parallel or subsequent to SR.
Of special interest are our findings indicating that aged
patients are more responsive to acute taVNS than younger
ones, as revealed by HRV tests. Our results are preliminary and
appropriate controls are missing, but if age-related differences
in HRV responses hold true also in controlled studies, it may
open new avenues for the treatment of hearing disorders,
particularly the two most common disorders, presbyacusis and
NIHD. There is no effective treatment available for them today.
Targeting neuroinflammation with taVNS might be a novel
therapeutic possibility for NIHD with tinnitus. There is strong
preclinical scientific evidence of the beneficial role of VNS
in the treatment of immunologic reflex-associated disorders,
particularly rheumatoid arthritis [reviewed by Tracey (2018)].
As a method taVNS is safer than VNS, because ABVN has no
efferent neurons.
In the pathogenesis of AF, another common medical entity,
accumulating evidence indicates that the inflammatory pathways
play a significant role (Aviles et al., 2003; Hu et al., 2015). In
a recent clinical trial, chronic, intermittent taVNS (with the
Salustim device used in this study as well) resulted in lower
AF burden in about 50% of patients compared to sham control
stimulation. These results support the use of taVNS to treat
paroxysmal AF in selected patients (Stavrakis et al., 2020).
How to Improve the Efficacy of taVNS?
The stimulation of ABVN is an easy and non-invasive method
to obtain the beneficial effects of vagal system activation.
However, there are still uncertainties concerning the modes
of stimulation, including the optimal stimulation site and
parameters. These can be defined only after the appropriate
biomonitoring tests become available. While clinical taVNS
applications have been widely noted in the literature, the
physiological mechanisms supporting such clinical effects are
poorly understood, particularly in humans.
May be the most important proof of the usefulness of taVNS
has so far been obtained from clinical studies. taVNS has been
employed for patients suffering from various disorders, including
epilepsy (Stefan et al., 2012), tinnitus (Lehtimäki et al., 2013;
Yakunina et al., 2018), depression (Rong et al., 2012; Hein et al.,
2013), pain (Napadow et al., 2012; Laqua et al., 2014; Janner et al.,
2018) and migraine (Straube et al., 2015; Garcia et al., 2017).
Clinical studies do not, however, directly show that the beneficial
effects are due to ABVN stimulation. This is because the outer
ear has an innervation not only from the cranial nerve X, but also
from the cranial nerves VII and V as well as the cervical plexus.
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FIGURE 6 | (A) Summary of the hypothesis. Noise exposure (most commonly music) causes dysfunction/damage in the high-frequency (>6.0 kHz) region of the
cochlea) in >85% of patients. This leads to high-pitched tinnitus, most commonly at about 8.0 kHz. Bioelectrical impulse flow from the damaged cochlear region
toward auditory cortex diminishes or ceases (”dead” region). This leads to reduced (inhibitory) regulation with subsequent neuronal hyperactivity in the central
auditory pathway, first in the auditory nuclei of brainstem, later in the auditory cortex. The normal (spontaneous) alpha activity (in EEG) changes to gamma activity.
(Continued)
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FIGURE 6 | Continued
The central auditory pathway is intimately connected to the limbic system (that controls emotions). Tinnitus is experienced as an emotionally negative sensation
including uncertainties and fears (”what is this all about?”; ”does it ever go away?”). Thereby, the perceptive (hearing) network is connected to the distress network
(stress). The stressor leads to imbalance of the central autonomous network (CAN) with hyperactivity of the sympathetic nervous system (flight or fight or freeze
response) and, correspondingly reduced activity of the parasympathetic nervous system (PNS) (relax, calm down). (B) Vagus nerve is the main player of the PNS.
Therefore, activation of the vagal system increases PNS activity. For taVNS we have used a specially designed Salustim device that uses an ear-clip electrode
inserted to the tragus and electrically stimulates ABVN. The taVNS reverses sympathetic hyperactivity in the limbic system and the CAN imbalance toward
parasympathetic direction. Reduction of distress also facilitates the reversal of gamma-hyperactivity back to normal alpha-activity in the auditory central pathway.
Much of our present understanding of the mechanisms and
presumed efficacy of taVNS comes from fMRI studies. These
studies have shown that taVNS produces significant cortical
effects in the vagal afferent pathway. Thus, outer ear stimulation
in the regions innervated by ABVN activates afferent vagal
networks (Kraus et al., 2007; Dietrich et al., 2008; Frangos
et al., 2015; Yakunina et al., 2017; Badran et al., 2018a). These
studies have, however, failed to convincingly demonstrate that
taVNS activates the crucial brainstem nuclei such as NTS. This
has now changed when it was recently demonstrated using
a ultrahigh-field (7T) fMRI that taVNS evokes activation in
the ipsilateral NTS and upstream monoaminergic source nuclei
of the brainstem (Sclocco et al., 2019). This finding supports
the idea that the selective stimulation of ABVN is responsible
for NTS activation. Corresponding selective NTS activation,
comparable to tragal ABVN stimulation, may be possible by
using percutaneous ABVN stimulation (Kaniusas et al., 2019).
Percutaneous stimulation must, however, be considered as a
mini-invasive procedure, because the skin is penetrated. It may
be appropriate for the treatment of diseases in medical offices,
but not for continuous home-therapy.
Importantly, NTS activity is known to be modulated by
respiration, both through the bottom-up afferent pathway
from pulmonary stretch receptors and aortic baroreceptors
and through the top-down effects from respiratory nuclei in
the medulla (Sclocco et al., 2019). Specifically, NTS receives
inhibitory influence during inhalation and facilitatory influence
during exhalation (Miyazaki et al., 1999; Baekey et al., 2010).
Therefore, it has been proposed that NTS targeted by taVNS can
be enhanced by gating stimulation to the exhalation phase of
the respiratory cycle via respiration-gated auricular vagal afferent
nerve stimulation (RAVANS) (Napadow et al., 2012; Garcia et al.,
2017). Our taVNS treatment protocol includes instructions for
slow breathing (“Respiratory VNS”) (Gerritsen and Band, 2018),
but electrical stimulation in our device was not synchronized to
give electrical stimuli specifically during exhalation.
HRV
Because HRV is a biomonitor for ANS function, we also analyzed
HRV changes before and immediately after acute test-taVNS.
HRV as well as HR have been found to be useful in monitoring
the effects of taVNS (Clancy et al., 2014; Antonino et al.,
2017; De Couck et al., 2017; Ylikoski et al., 2017; Badran
et al., 2018b; Bretherton et al., 2019). Clancy et al. (2014)
demonstrated that 15 min of taVNS administered to the tragus
significantly increased HRV, at least partly through reduction
of sympathetic nerve activity. In addition, the acute taVNS has
been demonstrated to improve spontaneous baroreflex sensitivity
(BRS) that may be the most sensitive measure of ANS function
and thereby the parasympathetic activity (Antonino et al., 2017;
Bretherton et al., 2019). Normal aging is associated with increase
in sympathetic prevalence and/or decreases in the vagal tone
and overall variability, which is reflected in HRV (Stein et al.,
1997; Kuo et al., 1999). There is a general consensus that we
all have our own dominant parasympathetic and sympathetic
regulation that gradually decreases with advancing age due to
a significant reduction of nocturnal parasympathetic activity.
Hence, the preservation of parasympathetic function may serve
as a biomarker related to the healthy longevity and vitality in
late life span (Zulfiqar et al., 2010). In addition to normal aging,
a shift toward sympathetic prevalence may contribute to age-
related conditions, such as hypertension, heart failure and AF.
Evidence suggests that taVNS could play a role in ameliorating
these conditions. Bretherton et al. (2019) have suggested that age-
related autonomic dysfunction (decrease of HRV and BRS), QoL,
mood and sleep changes improve with taVNS administered daily
for 2 weeks. This is in line with our previous study (Ylikoski
et al., 2017) and also with the observations in the present study
showing that the HRV improvement after acute test-taVNS was
greater in elderly individuals (with TRMS) than in younger
ones. The findings of Bretherton et al. (2019) also point to the
influence of initial values in determining the magnitude and
direction of change following taVNS: high initial sympathetic
prevalence, tension, anger, depression as well as low energy
and sleep quality were associated with greater improvements of
HRV and BRS. This is also in line with our findings of HRV
changes after acute test-taVNS: when the HRV-RMSSD values
were correlated to clinical data, patients with high scores in
THI, tinnitus annoyance, sleep disturbances and anxiety showed
largest changes in RMSSD. Overall, our findings support the idea
of Bretherton et al. (2019), when they state: “considering the
ease of application and affordability of taVNS, there is significant
potential in attenuating symptoms associated with age-related
conditions and prolonging the period of healthy ageing.”
VSEP
Different physiological and neurophysiological tests have been
used to biomonitor the effects of taVNS. According to
the literature, VSEP is the most useful online biomonitor.
Therefore, we investigated whether VSEP could be used for our
biomonitoring purposes. In order to reveal the anatomic site
where VSEP arises (hypothetically NTS of the brainstem), we
registered VSEP responses using EGI GTEN 100 EEG system
with 256 electrodes (Palva and Palva, 2018) and with multiple
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stimulation parameters. We found a strong stimulation artifact
(0 ms) and thereafter oscillations at about 3 ms, previously
described to originate from the brainstem. We interpreted that
this response has a local origin, presumably arising from muscles
in the ear region, not in the brainstem, in accordance to Leutzow
et al. (2013). Therefore, we had to abandon VSEP as a biomarker
for taVNS. VSEP seemed to be unrelevant also because of the
low numbers (50–100) of epochs reported in prior VSEP studies
(Fallgatter et al., 2003; Polak et al., 2007). It is well known
that in the most commonly employed brainstem response test,
auditory brainstem response (ABR), the minimal number of
epochs needed for reliable results vary between 500 and 1000. We
are currently investigating whether other features of EEG could
be used as online biomonitoring methods for taVNS.
Limitations
The results of the present study should be interpreted with
caution because they only represent a retrospective clinical
cohort study. However, all our clinical data are based on
structured diagnostic forms and questionnaires that were used
in the management of the patient population. Furthermore, the
consistent improvement of HRV -a seemingly useful marker for
mental stress- in 80–90% of our patients suggests that taVNS
is a useful (adjunctive) therapeutic means in severe tinnitus.
This study encourages future controlled clinical studies on
the usefulness of taVNS in tinnitus. The major defect in our
retrospective study is the lack of appropriate controls and sham
procedures, which are the crucial components of prospective
randomized controlled trials (RCTs). Our patient population
consists of nonselective series in contrast to that of RTCs in
which participants are recruited through various procedures
enhancing the selection factor. This aspect is particularly
important when the target of investigation is such a common
symptom as mental stress.
CONCLUSION
TRMS is an example of a tinnitus-triggered stress condition in
which patients may benefit from taVNS. Our clinical data and
HRV results before and after test-taVNS suggest that patients
with TRMS have ANS imbalance with increased sympathetic
activity and, correspondingly, reduced parasympathetic function.
Acute test-taVNS increased parasympathetic activity, more in
elderly and patients with more severe stress symptoms. Although
our follow-up outcome study primarily aimed to study the TCPT
therapeutic efficacy in patients with TRMS, showing that this
therapeutic program alleviated tinnitus severity, the results can
also be interpreted such that the majority of stressed tinnitus
patients get additional benefit from taVNS as an adjunct therapy.
HRV seems to serve as an easy and rapid method for assessment
of SR and thereby ANS balance. Combining clinical data to
HRV results may be useful in selecting patients for taVNS. We
have now clinical experience on the long-term use of taVNS by
several of our patients. They have used taVNS daily for more
than 4 years without any adverse effects. They continue to use
the device because of subjective benefits. Currently, at the same
setting where the present study was performed, we offer taVNS
treatment for all our patients who show THI scores of 34 or
over. We regard this as an alternative to a possible need for
e.g., tranquilizers. However, taVNS should not be used as a solo
therapy but as an adjunct to a treatment program in which all the
constituents are aimed to restore the sympathovagal imbalance
through parasympathetic activation. Generally, this study offers
additional support to the idea that taVNS might offer a new,
targeted therapeutic tool for patients in whom sympathovagal
imbalance is involved. Furthermore, taVNS is patient-friendly
and of low-cost. However, as there are not (yet) appropriate
online biomarkers available for taVNS, there is still a great need
for additional research to find optimal therapeutic regimen as
well as better stimulating devices.
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